Atlas Trials

Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520

Clinical trial NCT03657381 · UNKNOWN

Trial details

NCT number
NCT03657381
Sponsor
Shandong New Time Pharmaceutical Co., LTD
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumor,Recurrent Solid Tumor,Lymphoma,Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma
Start date
2019-03-01
Primary completion
2021-02-08
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.